MarketResearchReport2021

  Host Cell Contaminant Testing Market 2022 The increasing demand for personalized medicine and advancements in biopharmaceuticals are some of the factors that are likely to drive the growth of the Host Cell Contaminant Testing Market Share. Increasing incidences of chronic diseases such as cancer and increasing R&D activities will create opportunities for the Host Cell Contaminant Testing Market Share in the future. Host cell contaminants are introduced during the process of expressing and producing biological drugs using cultured cells. The concentration of host cell proteins in samples from drug substances and downstream purification is determined by host cell contaminant testing. Host cell contaminant testing plays an important role in both the safety and efficacy of a medicine. The host cell contaminant testing is performed by various techniques, such as host cell protein assay (ELISA, Immunoligand Assay, SDS-PAGE, and Immunoblotting) and host cell DNA assay (Quantitative PCR

  Host Cell Protein Testing Market 2022 The global host cell protein (HCP) testing market is driven by several factors, such as developments in the biopharmaceutical field and growing R&D activities. Furthermore, the technological advancements in the HCP testing products will drive the market. Rising chronic diseases such as cancer are driving more R&D efforts to find viable treatments, contributing to market growth. According to the International Agency for Research on Cancer (IARC), the global burden of cancer in 2020 reached19.3 million cases and 10 million cancer deaths. Furthermore, according to the American Cancer Society, by 2040, the global burden of cancer will reach 27.5 million cases and 16.3 million cancer deaths. According to MRFR analysis, the global  Host Cell Protein Testing Market   is expected to register a  CAGR of~5.7% from 2021 to 2027. The industry players are focusing on new product development, obtaining product approvals from the regulatory bodies for m

  Cerebral Vascular Stent Market 2022 The global Cerebral Vascular Stent Market Growth is driven by several factors, such asthe rising prevalence of cerebral vascular diseases and the booming geriatric population. According to the World Stroke Organization (WSO)’s Global Stroke Fact Sheet 2019, 13 million new cases of stroke are diagnosed globally every year, and over 80 million people who have experienced a stroke are currently living. Furthermore, according to a report published by Mayo Clinic, the US, in May 2019, the most powerful non-modifiable risk factor for incident stroke is aging, and the risk doubles every ten years after the age of 55. Around three-quarters of all strokes occur in those over the age of 65. The frequency of incident strokes in the older population is likely to grow as the number of people aged 65 years rise. According to MRFR analysis, the global  Cerebral Vascular Stent Market   is expected to register a  CAGR of~9.0% from 2021 to 2027. The key players are

  Epilepsy Devices Market 2022 Epilepsy devices reduce seizures by sending regular, mild pulse of electric energy to the brain via the vagus nerve. It is also known as pacemaker for the brain. Epilepsy devices are implanted under the skin in the chest. A wire from the device is wound around the vagus nerve in the neck. The growth of epilepsy device is driven by the growing prevalence of epilepsy amongst geriatric population, increasing cases of brain injuries due to road accidents. However, lack of public awareness and availability of epilepsy devices in developing nations is likely to restrain the market growth.    The global  Epilepsy Devices Market   is expected to have a market value of  USD 2,648.73 million by 2027. Major Key Players: Some of the key players operating in the epilepsy device market are  LivaNova Plc (UK), Medtronic Plc (Ireland), Medpage Ltd (UK), Koninklijke Philips NV (Netherlands), Compumedics Limited (Australia), Natus Medical Incorporated (US), Nihon Kohden Co

  Compressed Air Treatment Equipment Market 2022 Global Compressed Air Treatment Equipment Market is driven by several factors, such as high product penetration across various end-use industries such as F&B, pharmaceuticals, chemicals, and others, rising demand from these industries to protect air compressors from corrosion or rust, and technological advancements in the compressed air treatment equipment are augmenting the market growth. According to MRFR analysis, Global  Compressed Air Treatment Equipment Market   is expected to register a  CAGR of 6.5 from 2020 to 2027  and hold a value of  USD 12,500 Million till 2027. A lot of established and emerging market players are dominating the global Compressed Air Treatment Equipment Market Share. The prominent players are involved in strategic agreements, product launches, and joint ventures to sustain their market position. For instance, in May 2017, Atlas Copco (US) acquired Pressure Compressors Ltd (Brazil) and related manufacture

  FFP2 Grade Protective Masks Market 2022 An FFP mask, a type of mask certified by the European Union, protects against particulates such as dust particles. It is also called a respiratory protection mask or simply a respirator. The number of reported COVID-19 cases has increased rapidly in several EU countries. Consequently, there have been shortages of personal protective equipment (PPE), in particular, respirators, or filtering face pieces (FFP) categories 2 and 3 (FFP2/FFP3). Global  FFP2 Grade Protective Masks Market   is expected to have a market value of  USD  6, 812.03 Million by 2027. Segment Analysis Global FFP2 Grade Protective Masks Market Forecast is segmented based on Type and Application. The FFP2 Grade Protective Masks Market Forecast, by type, has been segmented into flat-fold type and cup style. The large share of flat-fold design is due to its benefits, such as saving space and individual packaging. The global FFP2 Grade Protective Masks Market Forecast, by applicati

  Daptomycin Market 2022 Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces rose sports. Daptomycin is used for the treatment of various bacterial infections caused by gram-positive bacteria. The growth of the global Daptomycin Market can be attributed to the high demand of daptomycin due to rising infections in the bloodstream, and increasing complicated skin and skin structure infections. According to MRFR analysis, the Global  Daptomycin Market   is expected to register a  CAGR of 4.4%  during the forecast period 2020 to 2027 and reach  USD 5,122.7 Million by 2027. Furthermore, the rise of right-sided infective endocarditis, and daptomycin as an antibacterial drug, a bacterial metabolite and a member of calcium-dependent antibiotics, are also expected to fuel the market growth during the forecast period. However, increasing rates of infection with gram-positive bacteria and the rapid emergence of resistance to the new agent are expected to restrain

  Animal Model Market 2022 The growth of the global Animal Model Market is driven by various factors, such as the growing use in biomedical research to develop new treatment methods, to understand biocompatibility during drug development and cellular responsiveness of the implant at an early stage. Due to all these factors, the demand for animal models is growing in the healthcare sectors. There are large numbers of players involved in the development of new animal model technologies. Some of the key companies operating in this market are Janvier Labs, GenOway S.A., Charles River Laboratories, Taconic Laboratories, and others. According to MRFR analysis, Global  Animal Model Market   is expected to register a  CAGR of 7.8% d uring the forecast period of 2020 to 2027 and is anticipated to reach  USD 3,632.48 Million by 2027. However, alternatives such as cell cultures, computer models, & tissue cultures and also the ethical issues on using animals for research activities hamper the

  Avian Influenza Vaccine 2022 Avian influenza or bird flu is a virus which affects wild and domestic birds such as geese, duck, chicken, and turkeys. Some strains of the virus have a potential of creating a pandemic similar to the COVID-19 virus and can be transmitted to humans. The global Avian Influenza Vaccine industry report by Market Research Future (MRFR) stresses on the developments in vaccines, clinical trials, and its potential for the period of 2019 to 2025 (forecast period). It also touches on the impact of the COVID-19 virus on the market. Market Scope The global  Avian Influenza Vaccine industry  is predicted to reach USD 735.22 million by 2025. It can garner revenues at 7.25% CAGR over the forecast period. Large cases of avian diseases are one of the biggest drivers of the market. The sudden outbreak of avian flu in 2008 has culminated in culling of birds on a large scale. In order to avoid a repeat of the incident, vaccine manufacturers are investing in research and dev

  Heart Failure Drugs Market 2022 Global  Heart Failure Drugs Market   is estimated to be valued at  USD 13,069.75 Million by 2025  and is expected to register a  CAGR of 17.79%  during the forecast period. Heart failure is a chronic condition in which the heart muscle is unable to pump enough blood to the body’s need for blood and oxygen. This results in fatigue and shortness of breath and sometimes results in a cough. Factors such as rising cases of cardiovascular disorders, increasing geriatric population, and the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure are driving the market growth. Additionally, a strong pipeline and product approvals are also driving the market growth. However, serious side-effects hamper the growth of the market. Major Key Players: Market Research Future (MRFR) recognizes  Amgen In